IRIS
ZULIANI, Valentina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.541
EU - Europa 1.485
AS - Asia 625
AF - Africa 23
SA - Sud America 4
Totale 3.678
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.516
CN - Cina 465
FI - Finlandia 336
SE - Svezia 278
IE - Irlanda 261
UA - Ucraina 193
IT - Italia 170
DE - Germania 131
SG - Singapore 105
GB - Regno Unito 47
TR - Turchia 41
CA - Canada 25
CI - Costa d'Avorio 23
BE - Belgio 16
AT - Austria 14
IN - India 12
CZ - Repubblica Ceca 11
FR - Francia 9
PT - Portogallo 6
CL - Cile 3
NL - Olanda 3
IR - Iran 2
LT - Lituania 2
RU - Federazione Russa 2
BG - Bulgaria 1
BR - Brasile 1
EE - Estonia 1
ES - Italia 1
LI - Liechtenstein 1
RO - Romania 1
RS - Serbia 1
Totale 3.678
Salva come PNG Salva come JPEG
Città #
Chandler 279
Dublin 261
Jacksonville 214
Ann Arbor 119
Beijing 106
Dearborn 101
Ashburn 86
Boardman 82
Nanjing 81
Singapore 75
Princeton 51
Shanghai 49
Izmir 41
Parma 41
San Mateo 40
New York 36
Wilmington 35
Milan 29
Bremen 25
Abidjan 23
Hebei 23
Los Angeles 23
Shenyang 23
Toronto 23
Helsinki 22
Nanchang 22
Jinan 20
Kunming 19
Brussels 16
Hefei 16
Vienna 14
Des Moines 13
Seattle 13
Guangzhou 12
Jiaxing 12
Woodbridge 12
Santa Clara 9
Auburn Hills 7
Changsha 7
Norwalk 7
Pune 7
Tianjin 7
Brno 6
Piacenza 6
Reggio Emilia 6
Chengdu 5
Dallas 5
Haikou 5
Marseille 5
Modena 5
Reggio Nell'emilia 5
Abbiategrasso 4
Bologna 4
Brescia 4
Falls Church 4
Munich 4
Roncadelle 4
Taiyuan 4
Augusta 3
Borås 3
Buccinasco 3
Castelo Branco 3
Düsseldorf 3
Grafing 3
Gualtieri 3
Hangzhou 3
Houston 3
Leipzig 3
London 3
Pavia 3
St Andrews 3
Taizhou 3
Xian 3
Zhengzhou 3
Castelcovati 2
Cereda 2
Cesena 2
Chongqing 2
Fairfield 2
Florence 2
Fuzhou 2
Hertford 2
Lanzhou 2
Magdeburg 2
Miami 2
Montepulciano 2
Naples 2
Oakville 2
Quzhou 2
Wuhan 2
Ardabil 1
Atlanta 1
Baotou 1
Brooklyn 1
Changchun 1
Changle 1
Charlotte 1
Chicago 1
Frankfurt am Main 1
Grezzago 1
Totale 2.267
Salva come PNG Salva come JPEG
Nome #
2-Aminobenzimidazoles as new potent H3-antagonists 116
The Role of HB-Donor Groups in the Heterocyclic Polar Fragment of H3-Antagonists. I. Synthesis and Biological Assays 96
Access to CNS of selected H3-antagonists: ex vivo binding study in rats 95
QSAR study of 2-aminobenzimidazole derivatives as H3 antagonists 94
5-Benzylidene-hydantoins as new EGFR inhibitors with antiproliferative activity 93
Cognition enhancing effect in rats of a selected histamine H3 receptor antagonist with good brain penetration 91
Synthesis and 3D-QSAR Analysis of H3 Receptor Antagonists Containing a Neutral Heterocyclic Polar Group 91
Aminobenzimidazoles as new potent H3-antagonists 89
5-Benzylidene-hydantoins: synthesis and antiproliferative activity on A549 lung cancer cell line 88
3D proteome-wide scale screening and activity evaluation of a new ALKBH5 inhibitor in U87 glioblastoma cell line 86
Synthesis and biological assays of new H3-antagonists with imidazole and imidazoline polar groups 86
Antiproliferative and proapototic effects of a new combi-molecule on non small cell lung cancer cell lines 85
Meccanismo d’azione di UPR 1024: un nuovo farmaco con attività antiproliferativa in cellule di carcinoma polmonare umano 83
A Short and Efficient Synthesis of the Selective H4 Receptor Agonist 4-Methylhistamine 82
Discovery of antitubercular 2,4-diphenyl-1H-imidazoles from chemical library repositioning and rational design 81
CNS access of selected H3-antagonists: ex vivo binding study in rats 80
Novel Sodium Channel Antagonists in the Treatment of Neuropathic Pain 80
Drug repurposing approaches to fight Dengue virus infection and related diseases 78
Chiral NMR discrimination of the diastereoisomeric salts of the H(3)-antagonist 2-[3-(1H-imidazol-4-ylmethyl)piperidin-1-yl]-1H-benzimidazole. 76
Access to CNS of selected H3-antagonists: ex vivo binding study in rats 76
5-benzylidene-hydantoin UPR 1024 acts as EGFR inhibitor and induces DNA damage in A549 NSCLC cell line 76
Synthesis, biological activity, QSAR and QSPR study of 2/aminobenzimidazole derivatives as potent H3-antagonists 75
Development of a GPCR model for SAR interpretation of classical and new H3 antagonists 75
Advances in Design and Development of Sodium Channel Blockers. 72
Dual mechanisms of action of the 5-benzylidene-hydantoin UPR1024 on lung cancer cell lines 72
5-benzylidene-hydantoins as new inhibitors of cell proliferation 71
2,4(5)-Diarylimidazoles: Synthesis and Biological Evaluation of a New Class of Sodium Channel Blockers against hNav1.2 70
Imidazole H3-antagonists: Relationship between Structure and Ex-vivo binding to Rat Brain H3-Receptors 70
Structure-Property Relationships on Histamine H3-Antagonists: Binding of Phenyl-substituted Alkylthioimidazole Derivatives to Rat Plasma Proteins 68
NMR Analysis of a Series of Imidazobenzoxazines 67
Relationship between structure and ex-vivo binding of imidazole H3 antagonists to rat brain H3 receptors 66
Three-Dimensional Quantitative Structure-Activity Relationship Studies on Selected MT1 and MT2 Melatonin Receptor Ligands: Requirements for Subtype Selectivity and Intrinsic Activity Modulation 66
Synthesis and biological evaluation of new non-imidazole H(3)-receptor antagonists of the 2-aminobenzimidazole series 66
Histamine H3-antagonists: the basicity of the polar group in quantitative structure-activity and structure-property relationship 65
2,4(5)-Diarylimidazoles as Inhibitors of hNaV1.2 Sodium Channels: Pharmacological Evaluationand Structure-Property Relationships 61
Inhibition of NaV1.6 sodium channel currents by a novel series of 1,4-disubstituted-triazole derivatives obtained via copper-catalyzed click chemistry 61
Sodium Channel Blocking Activity and In-vivo Testing of New Phenyl-imidazole Derivatives. 61
Anticonvulsant Activity of 2,4(5)-Diarylimidazoles in Mice and Rat Models 59
Biological evaluation of imidazobenzoxazines, imidazobenzoxazin-5-ones and imidazobenzoxazin-5-thiones as sodium channel blockers 57
Sodium channel blockers: a patent review (2010 - 2014) 55
Anticonvulsant Activity of 2,4(1H)-Diarylimidazoles in Mice and Rats Acute Seizure Models 54
A Practical Synthesis of 2,4(5)-Diarylimidazoles from Simple Building Blocks 54
Synthesis and stability in biological media of 1H-imidazole-1-carboxylates of ROS203, an antagonist of the histamine H3 receptor. 53
Sodium Channel Blockers as Therapeutic Target for Treating Epilepsy: Recent Updates 52
Recent Advances in the Medicinal Chemistry of Sodium Channel Blockers and their Therapeutic Potential 50
In vivo Screening of Diarylimidazoles as Anticonvulsant Agents 49
Sodium channel blockers for neuropathic pain. 48
Fluorescent Ligands for the Histamine H2 Receptor: Synthesis and Preliminary Characterization 45
Microwave Assisted Efficient Synthesis of Imidazole-based Privileged Structure 44
MV1035 Overcomes Temozolomide Resistance in Patient-Derived Glioblastoma Stem Cell Lines 41
null 36
Potential in-vitro antiviral activity of MV1035 on SARS-CoV-2 wild type viruses 34
pH-partition profiles of 4-(3-oxo-1,2-benzisothiazolin-2-yl)phenyl and phenoxyalkanoic acids 27
NEW ALKBH2 AND ALKBH5 INHIBITORS FOR TREATING GLIOBLASTOMA 23
Erratum: Fluorescent ligands for the histamine H 2 receptor: Synthesis and preliminary characterization (Bioorganic & Medicinal Chemistry (2004) 12 (6495-6503)) 23
New ALKBH2 and ALKBH5 inhibitors for treating glioblastoma 14
IMIDAZOBENZOXAZIN-5-THIONE (MV1035) TO OVERCOME THE BLOOD-BRAIN BARRIER AND TARGET CNS DISEASES 12
Totale 3.738
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.166
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.166
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020484 0 0 0 12 66 73 102 18 72 64 22 55
2020/2021374 6 52 35 12 43 6 54 11 73 16 61 5
2021/2022251 2 5 6 20 11 8 33 35 15 18 27 71
2022/20231.103 119 120 83 76 101 143 19 46 322 16 40 18
2023/2024400 14 41 13 11 39 96 40 23 17 23 31 52
2024/2025254 56 83 101 14 0 0 0 0 0 0 0 0
Totale 3.738